Trial intelligence / Profile preview

Fractional CO2 Laser With Topical Tioconazole vs Nd:YAG Laser in Onychomycosis

NCT05999474Phase 4Unknown

Sponsor
Cairo University
Start
Sep 2022
Primary completion
Sep 2023
Countries
1
01

Overview

Phase 4, randomised trial in onychomycosis (2 arms), sponsored by Cairo University. Primary endpoint: Treatment of onychomycosis at 6 months. Status: unknown.

02

Conditions

onychomycosis

Beyond the preview

Go deeper on NCT05999474.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05999474.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call